Format

Send to

Choose Destination
J Intellect Dev Disabil. 2006 Sep;31(3):131-8.

Community use of intranasal midazolam for managing prolonged seizures.

Author information

1
Children, Youth and Women's Health Service, South Australia. kyrkou.margaret@cyh.sa.gov.au

Abstract

BACKGROUND:

Until a few years ago, rectal diazepam (RD) was the only option available to parents and carers managing prolonged seizures. However, its use in the community was limited due to the requirement for privacy, and because education staff in South Australia are not permitted to carry out invasive procedures.

METHOD:

Following a literature review, a seizure management training package was developed to enhance the implementation of a trial treatment protocol for the administration of intranasal midazolam (INM). Parents, carers and education staff were later surveyed about their experiences and perceptions.

RESULTS:

Intranasal midazolam was administered to 131 people (51 children and 80 adults), with 96.9% control of seizures, and only one minor adverse event. Parents expressed a preference for INM over RD because of the shorter time it took to take effect and wear off, and the ability to administer it in public if necessary.

CONCLUSION:

Intranasal midazolam is a safe and practical alternative to rectal diazepam for managing prolonged seizures in the community.

PMID:
16954090
DOI:
10.1080/13668250600847021
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center